https://www.pharmaceutical-technology.com/news/ The leading site for news and procurement in the pharmaceutical industry Fri, 05 Jan 2024 21:07:36 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.2 https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2022/01/cropped-Pharmaceutical-Technology-Favicon-150x150.png https://www.pharmaceutical-technology.com/news/ 32 32 https://www.pharmaceutical-technology.com/news/amyriad-leaves-no-leaf-unturned-with-upcoming-phase-iii-alzheimers-trials/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/shutterstock_2086454953.jpg Fri, 05 Jan 2024 20:56:50 +0000 https://www.pharmaceutical-technology.com/uncategorized/amyriad-leaves-no-leaf-unturned-with-upcoming-phase-iii-alzheimers-trials/ https://www.pharmaceutical-technology.com/news/intellia-propels-into-2024-with-crispr-pipeline-updates/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/Intellia-image.jpg Fri, 05 Jan 2024 17:03:21 +0000 https://www.pharmaceutical-technology.com/news/intellia-propels-into-2024-with-crispr-pipeline-updates/ https://www.pharmaceutical-technology.com/news/insilico-teams-up-with-menarini-for-breast-cancer-kat6-inhibitor/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/GettyImages-1394005449-e1704470999875.jpg Fri, 05 Jan 2024 16:47:02 +0000 https://www.pharmaceutical-technology.com/news/insilico-teams-up-with-menarini-for-breast-cancer-kat6-inhibitor/ https://www.pharmaceutical-technology.com/news/rhythm-expands-obesity-portfolio-with-phase-ii-weight-loss-drug-for-100m/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/shutterstock_2159310393.jpg Fri, 05 Jan 2024 10:56:44 +0000 https://www.pharmaceutical-technology.com/?p=270888 https://www.pharmaceutical-technology.com/news/moma-roche-cancer-drug/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/MOMA-.jpg Fri, 05 Jan 2024 11:14:22 +0000 https://www.pharmaceutical-technology.com/news/moma-roche-cancer-drug/ https://www.pharmaceutical-technology.com/news/abbvie-umoja-therapies-cancer/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/AbbVie-.jpg Fri, 05 Jan 2024 11:09:59 +0000 https://www.pharmaceutical-technology.com/news/abbvie-umoja-therapies-cancer/ https://www.pharmaceutical-technology.com/news/boehringer-3t-cancer-immunotherapies/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/Boehringer.jpg Fri, 05 Jan 2024 08:49:20 +0000 https://www.pharmaceutical-technology.com/news/boehringer-3t-cancer-immunotherapies/ https://www.pharmaceutical-technology.com/news/avistone-drug-financing/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/laboratory-5721244_1920.jpg Fri, 05 Jan 2024 08:44:21 +0000 https://www.pharmaceutical-technology.com/news/avistone-drug-financing/ https://www.pharmaceutical-technology.com/news/signal-uk-online-pharmacies-selling-prescription-drugs-without-proper-checks/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/Benzos.jpg Fri, 05 Jan 2024 18:15:59 +0000 https://www.pharmaceutical-technology.com/news/signal-uk-online-pharmacies-selling-prescription-drugs-without-proper-checks/ https://www.pharmaceutical-technology.com/news/innate-pharma-forges-ahead-with-lacutamab-trial-post-fda-investigation/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/clinical-trial-image.jpg Thu, 04 Jan 2024 16:54:32 +0000 https://www.pharmaceutical-technology.com/news/innate-pharma-forges-ahead-with-lacutamab-trial-post-fda-investigation/ https://www.pharmaceutical-technology.com/news/tango-therapeutics-doses-first-patient-with-usp1-inhibitor-trial/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/GettyImages-1404416774-e1704377491130.jpg Thu, 04 Jan 2024 14:33:58 +0000 https://www.pharmaceutical-technology.com/uncategorized/tango-therapeutics-doses-first-patient-with-usp1-inhibitor-trial/ https://www.pharmaceutical-technology.com/news/cvs-to-remove-humira-from-reimbursement-lists-in-biosimilar-push/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/shutterstock_1481826875.jpg Thu, 04 Jan 2024 15:06:23 +0000 https://www.pharmaceutical-technology.com/news/cvs-to-remove-humira-from-reimbursement-lists-in-biosimilar-push/ https://www.pharmaceutical-technology.com/news/agioss-mitapivat-meets-endpoints-in-phase-iii-thalassemia-trial/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/shutterstock_1027735978.jpg Thu, 04 Jan 2024 10:49:33 +0000 https://www.pharmaceutical-technology.com/?p=269878 https://www.pharmaceutical-technology.com/news/esperion-daiichi-sankyo-europe-partnership/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/Daiichi-Sankyo.jpg Thu, 04 Jan 2024 10:51:10 +0000 https://www.pharmaceutical-technology.com/news/esperion-daiichi-sankyo-europe-partnership/ https://www.pharmaceutical-technology.com/news/bridgene-galapagos-oncology-drugs/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/BridGene-.jpg Thu, 04 Jan 2024 10:44:59 +0000 https://www.pharmaceutical-technology.com/news/bridgene-galapagos-oncology-drugs/ https://www.pharmaceutical-technology.com/news/pfizer-approval-haemophilia-b-therapy/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/Pfizer.jpg Thu, 04 Jan 2024 08:24:11 +0000 https://www.pharmaceutical-technology.com/news/pfizer-approval-haemophilia-b-therapy/